CERCAM and colorectal cancer: Based on an analysis of the upregulated genes in the TME that were evaluated through a Kaplan–Meier survival analysis using colorectal cancer data from TCGA, CERCAM was found to be associated with a poor survival and epithelial to mesenchymal transition (EMT) [34].